Shaperon (XKRX:378800) Scaled Net Operating Assets : 0.04 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shaperon Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shaperon's operating assets for the quarter that ended in Dec. 2024 was ₩3,914.46 Mil. Shaperon's operating liabilities for the quarter that ended in Dec. 2024 was ₩3,002.20 Mil. Shaperon's Total Assets for the quarter that ended in Sep. 2024 was ₩24,314.69 Mil. Therefore, Shaperon's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.04.

Shaperon Scaled Net Operating Assets Historical Data

The historical data trend for Shaperon's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaperon Scaled Net Operating Assets Chart

Shaperon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

-7.28

-0.02

-0.09

-0.02

0.04

Shaperon Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial										-0.02	-0.02	-0.03	-0.02	0.04

Competitive Comparison of Shaperon's Scaled Net Operating Assets

For the Biotechnology subindustry, Shaperon's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shaperon's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shaperon's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shaperon's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Shaperon Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shaperon's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(3914.46	-	3002.201)	/	25008.602
=	0.04

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	19283.685	-	15369.225
=	3914.46

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3283.507	-	5.614	-	275.692
=	3002.201

Shaperon's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(3914.46	-	3002.201)	/	24314.692
=	0.04

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	19283.685	-	15369.225
=	3914.46

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3283.507	-	5.614	-	275.692
=	3002.201

Shaperon Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shaperon's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shaperon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shaperon Inc (XKRX:378800) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gangnam Ace Tower G9, Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu, Seoul, KOR, 06373

Website

http://www.shaperon.com

Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.

Shaperon Headlines

No Headlines